Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Innoviva, Inc. | Director | Common Stock | 123K | $1.98M | $16.13 | Jun 17, 2024 | Direct |
AMARIN CORP PLC\UK | Director | Stock Option (right to buy) | 180K | Apr 18, 2024 | Direct | ||
Armata Pharmaceuticals, Inc. | Director | Stock Options (Right to Buy) | 94K | Mar 14, 2024 | Direct | ||
AMARIN CORP PLC\UK | Director | Restricted Stock Unit | 50.3K | Apr 18, 2024 | Direct | ||
Innoviva, Inc. | Director | Non-statutory Stock Option | 30K | Jun 17, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
INVA | Innoviva, Inc. | Jun 17, 2024 | 2 | $0 | 4 | Jun 20, 2024 | Director |
AMRN | AMARIN CORP PLC\UK | Apr 18, 2024 | 2 | $0 | 4 | Apr 19, 2024 | Director |
ARMP | Armata Pharmaceuticals, Inc. | Mar 14, 2024 | 2 | $0 | 4 | Mar 18, 2024 | Director |
ARMP | Armata Pharmaceuticals, Inc. | Dec 21, 2023 | 1 | $0 | 4 | Dec 26, 2023 | Director |
AMRN | AMARIN CORP PLC\UK | Jul 21, 2023 | 4 | $0 | 4 | Jul 21, 2023 | Director |
INVA | Innoviva, Inc. | May 22, 2023 | 2 | $0 | 4 | May 24, 2023 | Director |
AMRN | AMARIN CORP PLC\UK | Feb 28, 2023 | 0 | $0 | 3 | Mar 10, 2023 | Director |
INVA | Innoviva, Inc. | Apr 25, 2022 | 2 | $100M | 4 | Apr 27, 2022 | Director |
ARMP | Armata Pharmaceuticals, Inc. | Apr 13, 2022 | 1 | $0 | 4 | Apr 15, 2022 | Director |
ARMP | Armata Pharmaceuticals, Inc. | Jun 7, 2021 | 1 | $0 | 4 | Jun 9, 2021 | Director |
INVA | Innoviva, Inc. | May 14, 2021 | 1 | $0 | 4 | May 20, 2021 | Director |